vs
Side-by-side financial comparison of HARROW, INC. (HROW) and IMAX CORP (IMAX). Click either name above to swap in a different company.
IMAX CORP is the larger business by last-quarter revenue ($125.2M vs $89.1M, roughly 1.4× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs 0.5%, a 6.9% gap on every dollar of revenue. On growth, IMAX CORP posted the faster year-over-year revenue change (35.1% vs 33.3%). IMAX CORP produced more free cash flow last quarter ($28.0M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 25.8%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
HROW vs IMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $125.2M |
| Net Profit | $6.6M | $637.0K |
| Gross Margin | 79.3% | 57.6% |
| Operating Margin | 17.5% | 19.3% |
| Net Margin | 7.4% | 0.5% |
| Revenue YoY | 33.3% | 35.1% |
| Net Profit YoY | -2.2% | -88.0% |
| EPS (diluted) | $0.20 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.1M | $125.2M | ||
| Q3 25 | $71.6M | $106.7M | ||
| Q2 25 | $63.7M | $91.7M | ||
| Q1 25 | $47.8M | $86.7M | ||
| Q4 24 | $66.8M | $92.7M | ||
| Q3 24 | $49.3M | $91.5M | ||
| Q2 24 | $48.9M | $89.0M | ||
| Q1 24 | $34.6M | $79.1M |
| Q4 25 | $6.6M | $637.0K | ||
| Q3 25 | $1.0M | $20.7M | ||
| Q2 25 | $5.0M | $11.3M | ||
| Q1 25 | $-17.8M | $2.3M | ||
| Q4 24 | $6.8M | $5.3M | ||
| Q3 24 | $-4.2M | $13.9M | ||
| Q2 24 | $-6.5M | $3.6M | ||
| Q1 24 | $-13.6M | $3.3M |
| Q4 25 | 79.3% | 57.6% | ||
| Q3 25 | 75.3% | 63.1% | ||
| Q2 25 | 74.5% | 58.5% | ||
| Q1 25 | 67.5% | 61.4% | ||
| Q4 24 | 78.8% | 52.2% | ||
| Q3 24 | 75.6% | 55.8% | ||
| Q2 24 | 74.4% | 49.4% | ||
| Q1 24 | 69.5% | 59.3% |
| Q4 25 | 17.5% | 19.3% | ||
| Q3 25 | 20.6% | 27.2% | ||
| Q2 25 | 17.9% | 15.6% | ||
| Q1 25 | -23.5% | 19.3% | ||
| Q4 24 | 19.3% | 10.3% | ||
| Q3 24 | 2.7% | 21.2% | ||
| Q2 24 | 3.1% | 3.2% | ||
| Q1 24 | -20.0% | 15.3% |
| Q4 25 | 7.4% | 0.5% | ||
| Q3 25 | 1.4% | 19.4% | ||
| Q2 25 | 7.8% | 12.3% | ||
| Q1 25 | -37.2% | 2.7% | ||
| Q4 24 | 10.1% | 5.7% | ||
| Q3 24 | -8.6% | 15.2% | ||
| Q2 24 | -13.2% | 4.0% | ||
| Q1 24 | -39.2% | 4.1% |
| Q4 25 | $0.20 | $0.02 | ||
| Q3 25 | $0.03 | $0.37 | ||
| Q2 25 | $0.13 | $0.20 | ||
| Q1 25 | $-0.50 | $0.04 | ||
| Q4 24 | $0.19 | $0.09 | ||
| Q3 24 | $-0.12 | $0.26 | ||
| Q2 24 | $-0.18 | $0.07 | ||
| Q1 24 | $-0.38 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $151.2M |
| Total DebtLower is stronger | $250.0M | — |
| Stockholders' EquityBook value | $52.4M | $337.9M |
| Total Assets | $399.5M | $894.0M |
| Debt / EquityLower = less leverage | 4.77× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $72.9M | $151.2M | ||
| Q3 25 | $74.3M | $143.1M | ||
| Q2 25 | $53.0M | $109.3M | ||
| Q1 25 | $66.7M | $97.1M | ||
| Q4 24 | $47.2M | $100.6M | ||
| Q3 24 | $72.6M | $104.5M | ||
| Q2 24 | $71.0M | $91.6M | ||
| Q1 24 | $76.0M | $81.0M |
| Q4 25 | $250.0M | — | ||
| Q3 25 | $347.2M | — | ||
| Q2 25 | $250.6M | — | ||
| Q1 25 | $256.9M | — | ||
| Q4 24 | $262.7M | — | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — | ||
| Q1 24 | $243.4M | — |
| Q4 25 | $52.4M | $337.9M | ||
| Q3 25 | $47.0M | $349.5M | ||
| Q2 25 | $49.7M | $320.4M | ||
| Q1 25 | $56.5M | $299.5M | ||
| Q4 24 | $69.7M | $299.5M | ||
| Q3 24 | $58.0M | $289.4M | ||
| Q2 24 | $58.5M | $267.2M | ||
| Q1 24 | $60.6M | $258.8M |
| Q4 25 | $399.5M | $894.0M | ||
| Q3 25 | $363.1M | $889.6M | ||
| Q2 25 | $345.0M | $868.6M | ||
| Q1 25 | $364.2M | $848.3M | ||
| Q4 24 | $389.0M | $830.4M | ||
| Q3 24 | $351.5M | $847.6M | ||
| Q2 24 | $306.6M | $827.4M | ||
| Q1 24 | $295.5M | $824.1M |
| Q4 25 | 4.77× | — | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — | ||
| Q1 24 | 4.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | $29.4M |
| Free Cash FlowOCF − Capex | $8.1M | $28.0M |
| FCF MarginFCF / Revenue | 9.1% | 22.3% |
| Capex IntensityCapex / Revenue | 0.4% | 1.1% |
| Cash ConversionOCF / Net Profit | 1.27× | 46.11× |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | $118.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.4M | $29.4M | ||
| Q3 25 | $16.6M | $67.5M | ||
| Q2 25 | $-803.0K | $23.2M | ||
| Q1 25 | $19.7M | $7.0M | ||
| Q4 24 | $-17.8M | $11.5M | ||
| Q3 24 | $3.0M | $35.3M | ||
| Q2 24 | $-2.7M | $35.0M | ||
| Q1 24 | $-4.6M | $-11.0M |
| Q4 25 | $8.1M | $28.0M | ||
| Q3 25 | $16.4M | $64.8M | ||
| Q2 25 | $-969.0K | $20.9M | ||
| Q1 25 | $19.5M | $5.3M | ||
| Q4 24 | $-18.3M | $6.9M | ||
| Q3 24 | $2.3M | $34.2M | ||
| Q2 24 | $-3.1M | $33.5M | ||
| Q1 24 | $-4.7M | $-12.1M |
| Q4 25 | 9.1% | 22.3% | ||
| Q3 25 | 22.9% | 60.7% | ||
| Q2 25 | -1.5% | 22.8% | ||
| Q1 25 | 40.8% | 6.1% | ||
| Q4 24 | -27.4% | 7.4% | ||
| Q3 24 | 4.8% | 37.3% | ||
| Q2 24 | -6.3% | 37.6% | ||
| Q1 24 | -13.6% | -15.3% |
| Q4 25 | 0.4% | 1.1% | ||
| Q3 25 | 0.3% | 2.6% | ||
| Q2 25 | 0.3% | 2.6% | ||
| Q1 25 | 0.4% | 1.9% | ||
| Q4 24 | 0.8% | 5.0% | ||
| Q3 24 | 1.2% | 1.2% | ||
| Q2 24 | 0.7% | 1.8% | ||
| Q1 24 | 0.3% | 1.4% |
| Q4 25 | 1.27× | 46.11× | ||
| Q3 25 | 16.26× | 3.27× | ||
| Q2 25 | -0.16× | 2.06× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | -2.62× | 2.16× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 9.78× | ||
| Q1 24 | — | -3.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HROW
Segment breakdown not available.
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
